Literature DB >> 25623765

[Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with gastric cancer].

Shumei Li1, Xiaoli Xu, Di Liang, Guo Tian, Shan Song, Yutong He2.   

Abstract

OBJECTIVE: To explore the prognostic value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with gastric cancer.
METHODS: 591 cases of gastric cancer pathologically diagnosed at the Fourth Hospital of Hebei Medical University in 2006 were included in this study. The clinical information including age and gender, cancer, treatment, and the first blood test information at admission were collected from the medical record room and analyzed. The patients were followed up to March 15, 2012. The survival was calculated by Kaplan-Meier analysis. The differences between groups were compared using Log-rank test. Cox regression was used to analyze the factors which may affect the survival of the patients. Software SPSS 13.0 was used for statistical analysis.
RESULTS: In 2006, a total of 591 patients were enrolled in this study in accordance with the inclusion criteria. By the end of the study, 538 cases were followed up. The follow-up rate was 91.0%. Among them 353 cases died of gastric cancer, 185 patients are still alive. In the whole group of 538 cases, the 1-, 3-, and 5-year survival rate was 69.9%, 47.0%, and 37.5%, respectively. In the low NLR group, the 1-, 3-, and 5-year survival rate was 76.1%, 50.1%, and 42.7%, respectively, while those of the high NLR group was 53.1%, 38.6%, and 23.4%, respectively, showing a significant difference between the two groups (P < 0.05). Univariate analysis showed that the survival rate was significantly correlated with age, pathological type, TNM stage, operation, NLR and PLR (P < 0.05 for all). Multivariate analysis showed that TNM stage, operation, NLR and age of patients were independent risk factors for the prognosis of gastric cancer (P < 0.05 for all). According to the sub-site stratified analysis, TNM stage, operation and NLR were independent risk factors for gastric cardia adenocarcinoma (P < 0.05 for all), and age, TNM stage, operation for distal gastric cancer (P < 0.05 for all). PLR was not an independent prognostic factor of survival in patients with gastric cancer.
CONCLUSION: NLR may be an independent prognostic factor of gastric cancer.

Entities:  

Mesh:

Year:  2014        PMID: 25623765

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  14 in total

1.  Nomogram prediction for the survival of the patients with small cell lung cancer.

Authors:  Hui Pan; Xiaoshun Shi; Dakai Xiao; Jiaxi He; Yalei Zhang; Wenhua Liang; Zhi Zhao; Zhihua Guo; Xusen Zou; Jinxin Zhang; Jianxing He
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Impact of Antiplatelet and Anticoagulant Therapies on Platelet-related Prognostic Markers in Patients With Esophageal Cancer.

Authors:  Yusuke Ishibashi; Hironori Tsujimoto; Keita Kouzu; Yujiro Itazaki; Satoshi Tsuchiya; Seiichiro Fujishima; Yoshihisa Yaguchi; Hidekazu Sugasawa; Shinsuke Nomura; Nozomi Ito; Manabu Harada; Hiromi Nagata; Eiji Shinto; Yoji Kishi; Hideki Ueno
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer.

Authors:  Minjie Mao; Xiaoli Wei; Hui Sheng; Peidong Chi; Yijun Liu; Xiaoyan Huang; Yifan Xiang; Qianying Zhu; Shan Xing; Wanli Liu
Journal:  Oncol Lett       Date:  2017-10-13       Impact factor: 2.967

4.  Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.

Authors:  Lin Yang; Wenzhuo He; Pengfei Kong; Chang Jiang; Qiong Yang; Qiankun Xie; Liang Ping Xia
Journal:  BMC Cancer       Date:  2017-12-20       Impact factor: 4.430

5.  Prevalence rate and influencing factors of preoperative anxiety and depression in gastric cancer patients in China: Preliminary study.

Authors:  Le Xu; Qiong Pan; Renqin Lin
Journal:  J Int Med Res       Date:  2016-02-08       Impact factor: 1.671

6.  Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.

Authors:  Yan Zhang; Jing-Jing Lu; Yi-Ping Du; Chun-Xia Feng; Li-Qiang Wang; Min-Bin Chen
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

7.  Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis.

Authors:  Zhun Wang; Shuanghe Peng; Hui Xie; Linpei Guo; Ning Jiang; Zhiqun Shang; Yuanjie Niu
Journal:  Cancer Manag Res       Date:  2018-09-17       Impact factor: 3.989

8.  Prognostic value of systemic immune-inflammation index in patients with gastric cancer.

Authors:  Kang Wang; Feiyu Diao; Zhijun Ye; Xinhua Zhang; Ertao Zhai; Hui Ren; Tong Li; Hui Wu; Yulong He; Shirong Cai; Jianhui Chen
Journal:  Chin J Cancer       Date:  2017-09-12

Review 9.  Predictive biomarkers for tumor immune checkpoint blockade.

Authors:  Mengting Tong; Jing Wang; Wenting He; Yanling Wang; Hongming Pan; Da Li; Hongliang Zhang
Journal:  Cancer Manag Res       Date:  2018-10-11       Impact factor: 3.989

10.  Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.

Authors:  Xunlei Zhang; Wenjing Zhao; Yang Yu; Xue Qi; Li Song; Chenfei Zhang; Guoxing Li; Lei Yang
Journal:  World J Surg Oncol       Date:  2020-07-30       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.